Medigus: Charging Robotics to Receive Funding from the Israel Innovation Authority for Piloting its Wireless Charging Solution for Automated Parking System
November 22 2023 - 10:10AM
Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in
advanced medical solutions, innovative internet technologies, and
electric vehicle and charging solutions, announced today that
Charging Robotics Ltd., an innovator in wireless charging solutions
and a subsidiary of Fuel Doctor Holdings, Inc., (“FDOC”) a Delaware
corporation listed on the OTC Market (66.84% owned by Medigus),
received approval for funding from the Israeli Innovation Authority
for a pilot project that includes installing and demonstrating its
solution for wireless charging of electric vehicles (EVs) in
automated parking systems. The system will be installed and tested
in an automated parking system that was installed by Parkomot and
meets a growing need for charging EVs in automated parking systems,
where drivers aren’t able to connect a charging plug to the EV
socket. The total approved budget for this project is approximately
NIS 1.2 million ($445,000), of which the Israel Innovation
Authority will finance 50%.
The approval for the funding, provided by the
Israel Innovation Authority, was received after a rigorous due
diligence process regarding the technology, the market, the
competitive landscape and Charging Robotics’ team. The Israel
Innovation Authority provides support for Israeli companies with
cutting edge technologies which answer needs in large markets. One
of the acceptance criteria for this project was its alignment with
the Israeli Ministry of Energy’s needs, so the due diligence
process was conducted by Israel Innovation Authority project
officers as well as subject matter experts from the Israeli
Ministry of Energy. The Israeli Ministry of Energy promotes
technologies relating to electric transportation and found this
project in alignment with the goals for EV market
adoption.
About Charging Robotics
Charging Robotics is developing various
automatic wireless charging solutions such as robotic and
stationary charging systems for electric vehicles. Robotic
solutions are intended to offer the driver the ability to initiate
charging by use of a simple smartphone app so that an autonomous
robot will navigate under the vehicle and charge it.
Stationary systems offer various solutions for example in automatic
car parks allowing to charge EVs in places where drivers can’t
connect plugs to sockets. For further information,
visit: https://www.chargingrobotics.com/
About Parkomot
Parkomot, a subsidiary of Comtal Technologies
and Engineering Group, is a market leader in automatic parking
systems in Israel. Parkomot represents the South Korean
manufacturer Dong Yang Park, one of the world's leading
manufacturers in this field. For further information,
visit: https://parkomot.com
About Medigus
Based in Israel, Medigus Ltd. (Nasdaq: MDGS) is
a technology company focused on innovative growth partnerships,
mainly in advanced medical solutions, digital commerce and electric
vehicle markets. Medigus' affiliations in the medical solutions
arena include ownership in Polyrizon Ltd.. The Company’s affiliates
in digital commerce include Gix Internet Ltd., Jeffs' Brands Ltd.
and Eventer Technologies Ltd. In the electric vehicle market,
Charging Robotics Ltd. and Revoltz Ltd., by way of Fuel Doctor
Holdings, Inc. are also part of the Company’s portfolio of
technology solution providers. To learn more about Medigus’
advanced technologies, please
visit http://www.medigus.com/.
Forward-Looking Statements
This press release contains forward-looking
statements within the meaning of the “safe harbor” provisions of
the Private Securities Litigation Reform Act of 1995 and other
Federal securities laws. Words such as “expects,” “anticipates,”
“intends,” “plans,” “believes,” “seeks,” “estimates” and similar
expressions or variations of such words are intended to identify
forward-looking statements. Because such statements deal with
future events and are based on Medigus’ current expectations, they
are subject to various risks and uncertainties, and actual results,
performance or achievements could differ materially from those
described in or implied by the statements in this press
release.
The forward-looking statements contained or
implied in this press release are subject to other risks and
uncertainties, including those discussed in any filings with the
SEC. Except as otherwise required by law, Medigus undertakes no
obligation to publicly release any revisions to these
forward-looking statements to reflect events or circumstances after
the date hereof or to reflect the occurrence of unanticipated
events. References and links to websites have been provided as a
convenience, and the information contained on such websites is not
incorporated by reference into this press release. Medigus is not
responsible for the contents of third-party websites.
Company Contact: Tali DinarChief Financial
Officer+972-8-6466-880ir@medigus.com
Investor Relations Contact:Michal EfratyInvestor
Relations, Israel+972-(0)52-3044404michal@efraty.com
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Jul 2024 to Aug 2024
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Aug 2023 to Aug 2024